Novo Nordisk A/S (NYSE:NVO)
| 137.44 Delayed Data As of Jan 26 |  -0.10 / -0.07%Today’s Change | 92.69 Today|||52-Week Range 144.78 | +1.55% Year-to-Date |
Stock Price Forecast
The 24 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 147.78, with a high estimate of 174.72 and a low estimate of 75.50. The median estimate represents a +7.52% increase from the last price of 137.44.
Analyst Recommendations
The current consensus among 27 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since January, when it was unchanged from a rating.Move your mouse over past
months for detail
Earnings and Sales Forecasts
Current Quarter
Earnings per Share
$0.84
$0.84
Sales
$6.8B
$6.8B
Reporting Date
Feb 01
Feb 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.
Growthquarterly -0.69%
Growthannually 10.46%
Sales
Growthquarterly 12.38%
Growthannually 17.84%
